AI Model Names: Real or Random?
AI model names are often confusing. This article explores the reasons behind the chaos and proposes solutions for clarity, with a fun quiz to test your knowledge.
AI model names are often confusing. This article explores the reasons behind the chaos and proposes solutions for clarity, with a fun quiz to test your knowledge.
Nvidia faces a $5.5 billion impact due to tightened U.S. export rules to China concerning AI chips, highlighting tensions over technology and trade.
Oriental Supercomputing's MCP service aligns with global AI advancements, offering seamless integration and flexibility through the 'Oriental Six Harmonies' platform, democratizing AI access and fostering innovation.
AI-driven tools are revolutionizing research synthesis. This article examines AI's impact on literature reviews, highlighting benefits, challenges, and the future of AI-human collaboration in academic publishing.
This security checklist aids developers in identifying and mitigating risks associated with Model Context Protocol (MCP) in AI tools, ensuring a secure AI ecosystem.
China's genAI sector is rapidly growing, fueled by increased registered services, regulatory innovation, and overcoming tech constraints.
China's AI sector is surging, driven by open-source innovation, strategic investment, and government support, challenging Western dominance with companies like 01.AI and DeepSeek leading the charge.
The Model Context Protocol (MCP) is emerging as the 'USB-C for AI', enabling seamless communication between AI models, data, and tools. Propelled by industry leaders, multi-agent advancements, and ecosystem growth, MCP is transforming enterprise AI integration.
AI advancements are reshaping industries and driving growth, especially in the Global South. Addressing challenges and responsible deployment can unlock AI's benefits for all, creatinga more equitable future through education and skills development.
GenomOncology introduces BioMCP, an open-source protocol for AI access to medical data, enhancing research and clinical decision-making.